From medicalnewstoday.com
()
Breast cancers expressing the protein HER2 have a particularly poor prognosis. Treatment with trastuzumab (Herceptin) benefits some patients with HER2-positive breast cancer, but it is not as effective as had been hoped. Researchers are therefore seeking ways to enhance the effectiveness of trastuzumab. In this context, a team of researchers led by Ronald Levy, at Stanford University, Stanford, has identified a sequential treatment regimen...
- Enhancing the effectiveness of a breast cancer treatment (api.bing.com)
As a pro-life activist who also happens to be a breast cancer survivor, I was encouraged by the Susan G. Komen Foundation's recent announcement that it no longer would fund grants to Planned Parenthood Federation of America affiliates. I had never before ...
More perspectives...
From api.bing.com
()
#disgraceforthecure
In the last three weeks, the reputation of Susan G. Komen for the Cure has been threatened by a scandal that has uncovered some uncomfortable truths about the behind the scenes in the world of Professional Breast Cancer Awareness. Although the organization has given the media the "move along, nothing to see here" speech, it appears that Komen CEO Nancy Brinker's lavish...
More perspectives...
From gawker.com
()
Just in time for Breast Cancer Awareness Month, a new Northwestern study finds dietary supplements traditionally used to treat breast cancer patients may do more harm than good. Although concentrated soy was once marketed as beneficial for women ...
From api.bing.com
()
- Study finds soy negatively impacts breast cancer patients (api.bing.com)
The research paper titled Altered Pattern of Cervical Muscle Activation During Performance of a Functional Upper Limb Task in Breast Cancer Survivors has been awarded the Mention Winner of the 2011 Association of Academic Physiatrists Excellence ...
From api.bing.com
()
- Fasting May Boost Chemo By Weakening Cancer Cells (api.bing.com)
Roche Holding AG Wednesday said the U.S. Food and Drug Administration has accepted the company's Biologics License Application for pertuzumab and granted Priority Review. MAIN FACTS: - The proposed indication is pertuzumab in combination with Herceptin (trastuzumab) and docetaxel chemotherapy for people with HER2-positive metastatic or locally recurrent, unresectable breast cancer, who have not received...
From rss.biospace.com
()
- Komen's First Ever Breast Health Symposium, a Huge Success (api.bing.com)
Park City » Despite below-freezing temperatures and a less-than-stellar snow pack, more than 500 snowshoers tramped through Round Valley Saturday morning to raise money for breast cancer awareness and research. Like the Susan G. Komen’s popular Race for ...
From api.bing.com
()
- Komen's cuts to Planned Parenthood prompts community backlash (rss.news8austin.com)
Overview
Fight against breast cancer, with research, science, family, attitude, and proactive treatments. Breast cancer information and community.
Sorted by: Top Rated
